Nicola Heffron

Vermögen: 106 643 $ am 31.05.2024

52 Jahre

Health Technology

Consumer Services

Aktive Positionen von Nicola Heffron

Unternehmen	Position	Beginn	Ende
ALEXION PHARMACEUTICALS, INC.	Vertrieb & Marketing	01.04.2023	-

Unternehmen	Position	Beginn	Ende
2SEVENTY BIO, INC.	Geschäftsführer	04.11.2021	10.03.2023
CELGENE	Vertrieb & Marketing	01.05.2018	01.09.2018
BLUEBIRD BIO, INC.	Corporate Officer/Principal	01.01.2020	-

University of Warwick

Masters Business Admin

International

Vereinigte Staaten	5
Vereinigtes Königreich	2

Operativ

Sales & Marketing	2
Corporate Officer/Principal	1
Masters Business Admin	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BLUEBIRD BIO, INC.	Health Technology
2SEVENTY BIO, INC.	Health Technology

Private Unternehmen	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology

Private Unternehmen

Health Technology